Healthcare / Medical Care FacilitiesTokyo
$1108.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $6.3B · quality 73.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
52/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$100.3B
P/E
27.2x
↑EV/EBITDA
11.3x
↓ROE
17.5%
↑Gross Margin
16.3%
↓Debt/Equity
1.02
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.4%
FCF CAGR
+2.3%
FCF margin
3.7%
FCF / Net income
1.28x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $137.44B · net income $3.96B · FCF $5.05B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $137.44B | $137.44B | $135.14B | $131.09B | $117.24B |
| Net Income | $3.96B | $3.96B | $2.26B | $3.17B | $3.50B |
| EBITDA | $9.85B | $9.85B | $7.77B | $8.82B | $8.47B |
| EPS | 42.94 | 42.94 | 24.11 | 33.53 | 37.02 |
| Gross Margin | 16.3% | 16.3% | 16.2% | 16.6% | 17.5% |
| Operating Margin | 5.1% | 5.1% | 4.1% | 4.8% | 5.4% |
| Net Margin | 2.9% | 2.9% | 1.7% | 2.4% | 3.0% |
| Balance Sheet | |||||
| Debt/Equity | 1.02 | 1.02 | 1.39 | 1.20 | 1.42 |
| Current Ratio | 1.34 | 1.34 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $5.05B | $5.05B | $6.28B | $7.69B | $4.72B |
| Returns | |||||
| ROE | 17.5% | 17.5% | 11.0% | 14.7% | 17.4% |
| Valuation | |||||
| P/E | 27.18 | 27.18 | 21.07 | 17.92 | 25.96 |
| EV/EBITDA | 11.30 | 11.30 | 7.85 | 8.02 | 12.89 |
| P/B | 4.51 | 4.51 | 2.32 | 2.64 | 4.51 |
| Growth & Yield | |||||
| Revenue Growth | 1.7% | 1.7% | 3.1% | 11.8% | — |
| EPS Growth | 78.1% | 78.1% | -28.1% | -9.4% | — |
| Dividend Yield | 2.0% | 2.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
31.8%
EPS terminal req.
$98.32
Spread vs growth
46.3%
5Y implied EPS CAGR
22.6%
EPS terminal req.
$118.96
Spread vs growth
55.5%
10Y implied EPS CAGR
16.1%
EPS terminal req.
$191.59
Spread vs growth
62.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+166.4%
Start / end P/E
17.4x → 25.8x
EPS bridge
24.11 → 42.94
Residual
+37.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.